glp-1 covered by cigna glp 1 program RENŪ WALK-IN MEDICAL CARE Navigating Insurance Coverage for GLP-1

doi:10.1053/j.gastro.2025.06.003 13

Patients and Interventions/Exposure : New users of semaglutide (n= 613) and liraglutide (n=4,144), which are GLP-1 receptor agonists approved for diabetes, and users of buproprion-naltrexone (n= 654), an Federal Drug Administration (FDA)-approved weight loss agent, which served as active comparator

Dont wait to get help

This episode connects the dots between regulation, access, pricing, and normalization of obesity treatment, and explains why the people laughing today may be asking how they missed it tomorrow

W., Santelli, J

Densitometric band intensity analysis was performed using the ImageJ 2.0 software (National Institutes of Health), with GAPDH used for normalization